SANA — Sana Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- $1.91bn
- $1.70bn
- 12
- 12
- 84
- 29
Annual cashflow statement for Sana Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -131 | -285 | -356 | -269 | -283 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 40.5 | 135 | 84 | -43.7 | -13.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10.5 | 6.16 | 9.8 | 7.54 | 18.6 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -85.5 | -138 | -251 | -290 | -254 |
| Capital Expenditures | -26.1 | -23.9 | -29.9 | -20.9 | -20 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -61.7 | -229 | -216 | 231 | 192 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -87.9 | -253 | -246 | 211 | 172 |
| Financing Cash Flow Items | — | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 224 | 436 | 632 | 4.91 | 31.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 50.4 | 45.1 | 135 | -74.6 | -49.9 |